期刊文献+

尼古丁缓释贴剂的制备及体外透皮释药评价 被引量:6

Study on preparation and in vitro release characteristics of nicotine sustained-release patch
原文传递
导出
摘要 目的:制备尼古丁缓释贴剂并研究其体外释药性能及透皮吸收行为。方法:采用饱和水溶液法制备尼古丁-β-环糊精包合物,以水溶性高分子材料为基质制备尼古丁缓释贴剂,采用高效液相色谱法测定制剂中尼古丁的含量。利用Franz扩散池研究贴剂的透皮释药行为。结果:尼古丁经β-环糊精包合后,采用聚丙烯酸树脂EUDRAGIT E100为控释骨架和压敏胶材料,制备的尼古丁缓释贴剂体外释药行为符合Higuchi方程,且释药速率可通过改变促透剂的用量来进行调控。结论:所制备的尼古丁贴剂具有缓释作用。 Objective:To prepare nicotine patch and study its in vitro release characteristics. Methods: The inclusion complex was prepared by solution stirring method and nicotine patch was prepared with high polymer hydrophilic material as matrix. The determination method of nicotine was established by HPLC. The percutaneous absorption of nicotine patch was evaluated with the Franz diffusion cell. Results: The optimal combination of the formulation included EUDRAGIT E100 as the pressure sensitive adhesive and propylene glycol acted as the enhancer. The release mechanism of nicotine patch in vitro coincided with Higuchi Equation and the release rate was controlled by the dose of penetration. Conelusion: Nicotine patch is a sustained-release TDDS whose permeation speed is limited by skin.
出处 《中国新药杂志》 CAS CSCD 北大核心 2009年第8期755-758,768,共5页 Chinese Journal of New Drugs
关键词 尼古丁 缓释贴剂 Β-环糊精 HPLC nicotine sustained-release patches β-CD HPLC
  • 相关文献

参考文献10

  • 1DAVARAN S, RASHIDI MR, KHANDAGHI R, et al. Development of a novel prolonged-release nicotine transdermal patch [ J ]. Pharmacol Res,2005,51 (3) :233 - 237. 被引量:1
  • 2ROSE JE, BEHM FM, WESTMAN EC. Acute effects of nicotine andmecamylamine on tobacco withdrawal symptom, cigarette reward and ad lib smoking[ J]. Pharmacol Biochem Behav,2001, 68(2) :187 - 197. 被引量:1
  • 3FOSSE R, STICKGOLD R, HOBSON JA. Thinking and hallucinating : reciprocal changes in sleep [J]. Psychophysiology, 2004, 41 (2) :298 -305. 被引量:1
  • 4PONGJANYAKUL T, PRAKONGPAN S, PIPREM A. Acrylic matrix type nicotine transdermal patches:in vitro evaluations and batch-to-batch uniformity [ J ]. Drug Dev lnd Pharm, 2003,29 (8) :843 - 853. 被引量:1
  • 5PARK CR, DALE L. Munday development and evaluation of a biphasic buccal adhesive tablet for nicotine replacement therapy [ J ]. Int J Pharm,2002,23 (7) :215 - 226. 被引量:1
  • 6国家药典委员会编..中华人民共和国药典 2005年版 二部[M].北京:化学工业出版社,2005:924.
  • 7童林荟著..环糊精化学-基础与应用[M].北京:科学出版社,2001:384.
  • 8崔福德主编..药剂学[M].北京:人民卫生出版社,2004:471.
  • 9姚梅坤,韩雅峰,陈鸿清,陈金通,陈荔贞.盐酸尼卡地平贴剂的大鼠离体皮肤渗透研究[J].中国新药杂志,2003,12(7):545-547. 被引量:2
  • 10杜洪光,张恩宏,王丽,王树明,袁汉成,张强.可乐定透皮贴剂体外透皮性能研究[J].中国新药杂志,2004,13(8):712-715. 被引量:11

二级参考文献6

  • 1周建平,张钧寿,覃平.尼莫地平透皮促进剂的研究[J].中国药科大学学报,1994,25(3):149-152. 被引量:15
  • 2[1]Jarrot B,Comway EL,Maccarone C,et al.Clonidine:understanding disposition,sites and mechanism of action[J].Clin Exp Pharmacol,1987,14(3):471-479. 被引量:1
  • 3[2]Weber MA,Drayer JM.Clinical experience with rate-controlled delivery of antihypertensive therapy by a transdermal system[J].Clin Auton Res,1993,3(2):391-396. 被引量:1
  • 4[3]Burris JF.The USA experience with the clonidine transdermal the rapeutic system[J].Clin Auton Res,1993,3(2):397-399. 被引量:1
  • 5[5]Shaw JE.Pharmacokinetics of nitroglycerin and clonidine delivered by the transdermal route[J].Am Heart J,1984,108(1):217-222. 被引量:1
  • 6黄红深,李海虹.紫外分光光度法测定尼卡地平制剂含量[J].药物分析杂志,1990,10(6):359-360. 被引量:10

共引文献11

同被引文献76

引证文献6

二级引证文献18

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部